Premium Scalp Care Device ‘Hyper Shot’ Achieves Consecutive Sellouts on Home Shopping in Korea



The premium scalp care device Res Novae Hyper Shot, created through the combination of WITHNIX’s advanced manufacturing technology and Medifab’s expertise in planning and branding, is achieving remarkable success in the Korean home shopping market.
On September 20, during its launch broadcast on Hyundai Home Shopping, Hyper Shot sold out completely within minutes, receiving an enthusiastic response from viewers.
This followed consecutive sellouts on Lotte Home Shopping in July and GS Home Shopping in September,
marking three major channels in a row and establishing its position as a leading premium scalp care device.
Notably, during the Hyundai Home Shopping broadcast,
the device reached an unprecedented sales pace of one unit every 1.5 seconds, surpassing 130% of the sales target.
Hyper Shot is a differentiated scalp home-care device based on MICROPORATION technology, featuring a Dynamic Mode that delivers EP (Electroporation) and MC (Microcurrent) simultaneously, and a Calming Mode that supports scalp soothing and circulation care with EMS.
The device replicates the same routine offered in professional scalp care centers’ VIP programs, resulting in high customer satisfaction.
Currently, Res Novae is maintaining its strong sales momentum by collaborating with major Korean home shopping channels, including GS, Lotte, Hyundai, and CJ Home Shopping.
This success demonstrates the synergy of WITHNIX’s unrivaled R&D and production capabilities combined with Medifab’s market strategies.
Moving forward, WITHNIX will continue to strengthen partnerships based on differentiated technology and innovative production capacity,
striving to become a global leader in beauty devices that create new value in the worldwide market.
Through close collaboration with Medifab, we also plan to continuously introduce a wide range of innovative new products.
(*The sales rights for Hyper Shot are exclusively held by Medifab Co., Ltd.)
[Original Article]
https://www.mydaily.co.kr/page/view/2025092309534298326
September 23, 2025